Taxol Solution For Injection 6Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Taxol: Solution for injection (6mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PACLITAXEL (PAK li TAX el) is a chemotherapy drug. It targets fast dividing cells, like cancer cells, and causes these cells to die. This medicine is used to treat ovarian cancer, breast cancer, and other cancers.

In-Depth Information
Select a Medication

Taxol 30mg/5ml Solution for Injection

NDC: 000153475
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Ovarian Cancer, Kaposi's Sarcoma

Sometimes used for but not FDA approved for the following conditions:
Breast Cancer, Small Cell Lung Cancer (SCLC), Thymoma, Thymic Carcinoma, Non-small Cell Lung Cancer (NSCLC), Penile Cancer, Esophageal Cancer, Endometrial Cancer, Peripheral Blood Stem Cell (PBSC) Mobilization, Head And Neck Cancer, Bladder Cancer

Storage Information
Protect from light
Store in original container
Store at controlled room temperature (between 68 and 77 degrees F)
Taxol 30mg/5ml Solution for Injection

Reported Side Effects for Taxol 30mg/5ml Solution for Injection

Brain Dysfunction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Incoordination Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Blood Clot Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
1.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Heart Block Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Brain Deterioration Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: EARLY
Nail Discoloration Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
2.0-4.0%*
Severity: SEVERE
Onset: RAPID
Anaphylactoid Reactions Incidence:
2.0-4.0%*
Severity: SEVERE
Onset: RAPID
Slow Heart Beat Incidence:
3.0%*
Severity: SEVERE
Onset: RAPID
Nerve Pain Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Pressure Incidence:
4.0-12.0%*
Severity: MODERATE
Onset: RAPID
Low Platelet Count Incidence:
7.0%*
Severity: SEVERE
Onset: DELAYED
Yeast Infection Incidence:
7.0-9.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
8.0%*
Severity: SEVERE
Onset: EARLY
Joint Pain Incidence:
8.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
13.0%*
Severity: MILD
Onset: RAPID
Bleeding Incidence:
14.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
14.0%*
Severity: MODERATE
Onset: RAPID
Anemia Incidence:
16.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
17.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
19.0-22.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
21.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
28.0%*
Severity: MILD
Onset: RAPID
Infection Incidence:
30.0-61.0%*
Severity: MILD
Onset: DELAYED
Mouth Ulcers Incidence:
31.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
38.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
52.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
52.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
52.0%*
Severity: SEVERE
Onset: DELAYED
Paresthesias Incidence:
>60.0%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
87.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Taxol

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5